Nebius Forecast, price target & analysts
Why the stock moved Beta
Nebius Target price 2026 - Analyst rating & recommendation
Nebius Classifications & Recommendation
Nebius Price Target
| Target Price | $310.08 |
| Price | $171.99 |
| Potential | 80.29% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Nebius 2027 . The average Nebius target price is $310.08. This is 80.29% higher than the current stock price. The highest price target is $430.50 150.31% , the lowest is $145.44 15.44% . | |
| A rating was issued by 29 analysts: 20 Analysts recommend Nebius to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Nebius stock has an average upside potential 2027 of 80.29% . Most analysts recommend the Nebius stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
28 Analysts have issued a sales forecast Nebius 2026 . The average Nebius sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
24 Analysts have issued an Nebius EBITDA forecast 2026. The average Nebius EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
24 Nebius Analysts have issued a net profit forecast 2026. The average Nebius net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Nebius Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Oct 21 2026 |
| Rosenblatt |
➜
Buy
|
Initiated | Oct 08 2026 |
| William Blair |
➜
Outperform
|
Initiated | Sep 30 2026 |
| BNP Paribas |
Neutral
➜
Outperform
|
Upgrade | Sep 24 2026 |
| Rothschild & Co |
➜
Sell
|
Initiated | Sep 21 2026 |
| Truist Securities |
➜
Buy
|
Initiated | Sep 09 2026 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Aug 18 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Oct 21 2026 |
|
Initiated
Rosenblatt:
➜
Buy
|
Oct 08 2026 |
|
Initiated
William Blair:
➜
Outperform
|
Sep 30 2026 |
|
Upgrade
BNP Paribas:
Neutral
➜
Outperform
|
Sep 24 2026 |
|
Initiated
Rothschild & Co:
➜
Sell
|
Sep 21 2026 |
|
Initiated
Truist Securities:
➜
Buy
|
Sep 09 2026 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Aug 18 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
